Aspire Biopharma Holdings, Inc. (ASBP) vs Clearmind Medicine Inc. (CMND)
A side-by-side comparison of Aspire Biopharma Holdings, Inc. and Clearmind Medicine Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ASBP
Aspire Biopharma Holdings, Inc.
$8.88HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CMND
Clearmind Medicine Inc.
$6.00HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ASBP vs CMND
growth of $100 · dividends reinvested · last 4yASBP -99.9% (-83.6%/yr)CMND -100.0% (-94.3%/yr)ASBP compounded faster over this window
Log scale — wide-divergence pair
ASBP CMND
ASBP vs CMND: by the numbers
- •CMND is the larger company ($1M vs $1M market cap).
- •Both run net losses; CMND's is the smaller (0.00% vs -11314.24% net margin).
Metrics side by side
Valuation
| Metric | ASBP | CMND |
|---|---|---|
| P/S ratio | 10.49 | N/A |
| P/B ratio | 0.09 | 0.09 |
Profitability
| Metric | ASBP | CMND |
|---|---|---|
| Gross margin | -1.87% | 0.00% |
| Operating margin | -312016.95% | 0.00% |
| Net margin | -11314.24% | 0.00% |
| ROE | -93.97% | -57.87% |
| ROIC | -59.81% | -60.41% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.